Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

China · Delayed Price · Currency is CNY

21.32

-0.21 (-0.98%)

Feb 27, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Traditional Chinese Medicine	25.73M	-	-	-	-
Western Medicine	939.73K	-	-	-	-
Health Care Products	68.16M	-	-	-	-
Other	1.52M	-	-	-	-
Active Pharmaceutical Ingredient (API)	27.46M	-	-	-	-
Pharmaceuticals - Distribution Products	47.74M	-	-	-	-
Medical Machinery	2.47M	-	-	-	-
Service Type	42.89M	-	-	-	-
Total	216.91M	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	217.30M	121.78M	108.91M	147.07M	206.63M
China Growth	78.44%	11.82%	-25.95%	-28.82%	-30.45%
Total	217.30M	121.78M	108.91M	147.07M	206.63M
Total Growth	78.44%	11.82%	-25.95%	-28.82%	-30.45%

Source: S&P Global Market Intelligence.